Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-03-20 5:01 pm Sale | 13D | SpringWorks Therapeutics, Inc. SWTX | BC SW LP | 3,081,307 4.9% | -1,750,000![]() (-36.22%) | View |
2023-02-14 2:31 pm Sale | 13G | SpringWorks Therapeutics, Inc. SWTX | PERCEPTIVE ADVISORS LLC | 2,617,691 4.2% | -2,232,221![]() (-46.03%) | View |
2023-02-10 12:08 pm Purchase | 13G | SpringWorks Therapeutics, Inc. SWTX | STATE STREET CORP STT | 3,755,689 6.02% | 3,755,689![]() (New Position) | View |
2023-02-09 12:31 pm Purchase | 13G | SpringWorks Therapeutics, Inc. SWTX | FMR LLC | 9,360,090 15.004% | 3,313,881![]() (+54.81%) | View |
2023-02-09 11:32 am Purchase | 13G | SpringWorks Therapeutics, Inc. SWTX | VANGUARD GROUP INC | 4,322,355 6.93% | 1,460,043![]() (+51.01%) | View |
2023-02-07 12:59 pm Purchase | 13G | SpringWorks Therapeutics, Inc. SWTX | BlackRock Inc. BLK | 3,324,738 5.3% | 3,324,738![]() (New Position) | View |
2023-01-05 4:40 pm Sale | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 4,985,000 8% | -614,842![]() (-10.98%) | View |
2022-09-19 4:30 pm Purchase | 13G | SpringWorks Therapeutics, Inc. SWTX | Boxer Capital LLC | 3,421,541 5.7% | 3,421,541![]() (New Position) | View |
2022-09-19 08:27 am Purchase | 13G | SpringWorks Therapeutics, Inc. SWTX | EcoR1 Capital LLC | 3,460,208 5.5% | 3,460,208![]() (New Position) | View |
2022-09-14 4:34 pm Sale | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 5,599,842 9.3% | -586,465![]() (-9.48%) | View |
2022-09-13 4:30 pm Unchanged | 13D | SpringWorks Therapeutics, Inc. SWTX | BC SW LP | 4,831,307 8% | 0 (Unchanged) | View |
2022-04-11 09:01 am Purchase | 13G | SpringWorks Therapeutics, Inc. SWTX | FMR LLC | 6,046,209 12.253% | 2,099,889![]() (+53.21%) | View |
2022-02-14 9:12 pm Purchase | 13G | SpringWorks Therapeutics, Inc. SWTX | PERCEPTIVE ADVISORS LLC | 4,849,912 9.8% | 672,191![]() (+16.09%) | View |
2022-02-11 7:01 pm Sale | 13G | SpringWorks Therapeutics, Inc. SWTX | PFIZER INC PFE | 2,340,330 4.75% | -2,242,717![]() (-48.94%) | View |
2022-02-10 08:37 am Purchase | 13G | SpringWorks Therapeutics, Inc. SWTX | VANGUARD GROUP INC | 2,862,312 5.81% | 2,862,312![]() (New Position) | View |
2022-02-09 10:01 am Purchase | 13G | SpringWorks Therapeutics, Inc. SWTX | FMR LLC | 3,946,320 8.012% | 568,300![]() (+16.82%) | View |
2021-08-12 5:07 pm Sale | 13D | SpringWorks Therapeutics, Inc. SWTX | BC SW LP | 4,831,307 9.8% | -1,000,000![]() (-17.15%) | View |
2021-03-11 4:30 pm Sale | 13D | SpringWorks Therapeutics, Inc. SWTX | BC SW LP | 5,831,307 11.9% | -1,450,000![]() (-19.91%) | View |
2021-03-03 6:50 pm Sale | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 6,186,307 12.6% | -1,220,000![]() (-16.47%) | View |
2021-02-16 3:35 pm Purchase | 13G | SpringWorks Therapeutics, Inc. SWTX | PERCEPTIVE ADVISORS LLC | 4,177,721 8.6% | 880,199![]() (+26.69%) | View |